Cargando…

A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer

OBJECTIVE: Inflammation and malnutrition are common in patients with advanced lung cancer undergoing palliative care, and their survival time is limited. In this study, we created a prognostic model using the Inflam-Nutri score to predict the survival of these patients. METHODS: A retrospective coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Changyan, Yu, Huiqing, Lei, Haike, Cao, Haoyang, Chen, Mengting, Liu, Shihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115985/
https://www.ncbi.nlm.nih.gov/pubmed/35585628
http://dx.doi.org/10.1186/s12904-022-00972-x
_version_ 1784710030333837312
author Feng, Changyan
Yu, Huiqing
Lei, Haike
Cao, Haoyang
Chen, Mengting
Liu, Shihong
author_facet Feng, Changyan
Yu, Huiqing
Lei, Haike
Cao, Haoyang
Chen, Mengting
Liu, Shihong
author_sort Feng, Changyan
collection PubMed
description OBJECTIVE: Inflammation and malnutrition are common in patients with advanced lung cancer undergoing palliative care, and their survival time is limited. In this study, we created a prognostic model using the Inflam-Nutri score to predict the survival of these patients. METHODS: A retrospective cohort study was conducted on 223 patients with advanced, histologically confirmed unresectable lung cancer treated between January 2017 and December 2018. The cutoff values of the neutrophil-albumin ratio (NAR) and Patient-Generated Subjective Global Assessment (PG-SGA) score were determined by the X-tile program. Least absolute shrinkage and selection operator (LASSO) Cox regression and multivariate Cox regression analysis were performed to identify prognostic factors of overall survival (OS). We then established a nomogram model. The model was assessed by a validation cohort of 72 patients treated between January 2019 and December 2019. The predictive accuracy and discriminative ability were assessed by the concordance index (C-index), a plot of the calibration curve and risk group stratification. The clinical usefulness of the nomogram was measured by decision curve analysis (DCA). RESULTS: The nomogram incorporated stage, supportive care treatment, the NAR and the PG-SGA score. The calibration curve presented good performance in the validation cohorts. The model showed discriminability with a C-index of 0.76 in the training cohort and 0.77 in the validation cohort. DCA demonstrated that the nomogram provided a higher net benefit across a wide, reasonable range of threshold probabilities for predicting OS. The survival curves of different risk groups were clearly separated. CONCLUSIONS: The NAR and PG-SGA scores were independently related to survival. Our prognostic model based on the Inflam-Nutri score could provide prognostic information for advanced palliative lung cancer patients and physicians.
format Online
Article
Text
id pubmed-9115985
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91159852022-05-19 A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer Feng, Changyan Yu, Huiqing Lei, Haike Cao, Haoyang Chen, Mengting Liu, Shihong BMC Palliat Care Research OBJECTIVE: Inflammation and malnutrition are common in patients with advanced lung cancer undergoing palliative care, and their survival time is limited. In this study, we created a prognostic model using the Inflam-Nutri score to predict the survival of these patients. METHODS: A retrospective cohort study was conducted on 223 patients with advanced, histologically confirmed unresectable lung cancer treated between January 2017 and December 2018. The cutoff values of the neutrophil-albumin ratio (NAR) and Patient-Generated Subjective Global Assessment (PG-SGA) score were determined by the X-tile program. Least absolute shrinkage and selection operator (LASSO) Cox regression and multivariate Cox regression analysis were performed to identify prognostic factors of overall survival (OS). We then established a nomogram model. The model was assessed by a validation cohort of 72 patients treated between January 2019 and December 2019. The predictive accuracy and discriminative ability were assessed by the concordance index (C-index), a plot of the calibration curve and risk group stratification. The clinical usefulness of the nomogram was measured by decision curve analysis (DCA). RESULTS: The nomogram incorporated stage, supportive care treatment, the NAR and the PG-SGA score. The calibration curve presented good performance in the validation cohorts. The model showed discriminability with a C-index of 0.76 in the training cohort and 0.77 in the validation cohort. DCA demonstrated that the nomogram provided a higher net benefit across a wide, reasonable range of threshold probabilities for predicting OS. The survival curves of different risk groups were clearly separated. CONCLUSIONS: The NAR and PG-SGA scores were independently related to survival. Our prognostic model based on the Inflam-Nutri score could provide prognostic information for advanced palliative lung cancer patients and physicians. BioMed Central 2022-05-18 /pmc/articles/PMC9115985/ /pubmed/35585628 http://dx.doi.org/10.1186/s12904-022-00972-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Feng, Changyan
Yu, Huiqing
Lei, Haike
Cao, Haoyang
Chen, Mengting
Liu, Shihong
A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer
title A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer
title_full A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer
title_fullStr A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer
title_full_unstemmed A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer
title_short A prognostic model using the neutrophil-albumin ratio and PG-SGA to predict overall survival in advanced palliative lung cancer
title_sort prognostic model using the neutrophil-albumin ratio and pg-sga to predict overall survival in advanced palliative lung cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115985/
https://www.ncbi.nlm.nih.gov/pubmed/35585628
http://dx.doi.org/10.1186/s12904-022-00972-x
work_keys_str_mv AT fengchangyan aprognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer
AT yuhuiqing aprognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer
AT leihaike aprognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer
AT caohaoyang aprognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer
AT chenmengting aprognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer
AT liushihong aprognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer
AT fengchangyan prognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer
AT yuhuiqing prognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer
AT leihaike prognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer
AT caohaoyang prognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer
AT chenmengting prognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer
AT liushihong prognosticmodelusingtheneutrophilalbuminratioandpgsgatopredictoverallsurvivalinadvancedpalliativelungcancer